Parkinsonism & Related Disorders

Title Publication Date Language Citations
Serotonin and dopamine striatal innervation in Parkinson’s disease and Huntington’s chorea2011/09/01English64
Levodopa–carbidopa intestinal gel in advanced Parkinson's disease open-label study: Interim results2013/03/01English64
Cortical thickness changes in patients with Parkinson's disease and impulse control disorders2016/03/01English64
Diffusion alterations associated with Parkinson's disease symptomatology: A review of the literature2016/12/01English64
A comparative study of Lrrk2 function in primary neuronal cultures2010/12/01English64
Measurement of patient-centered outcomes in Parkinson’s disease: What do patients really want from their treatment?2011/02/01English64
Quantitative susceptibility mapping differentiates between parkinsonian disorders2017/11/01English63
Apomorphine - pharmacological properties and clinical trials in Parkinson's disease2016/12/01English63
Treatment effects for dysphagia in Parkinson's disease: A systematic review2014/08/01English63
Predictors of survival in a series of clinically diagnosed progressive supranuclear palsy patients2013/11/01English63
Nintendo Wii rehabilitation (“Wii-hab”) provides benefits in Parkinson's disease2013/11/01English63
The LRRK2 I2012T, G2019S, and I2020T mutations are rare in Taiwanese patients with sporadic Parkinson's disease2005/12/01English63
Is drooling secondary to a swallowing disorder in patients with Parkinson's disease?2008/04/01English63
Voxel-based magnetic resonance imaging study of structural brain changes in patients with idiopathic REM sleep behavior disorder2012/02/01English63
Classifying risk factors for dyskinesia in Parkinson’s disease2010/09/01English63
Minority enrollment in Parkinson's disease clinical trials2009/05/01English63
Voxel-based morphometry reveals extra-nigral atrophy patterns associated with dopamine refractory cognitive and motor impairment in parkinsonism2009/03/01English63
Altered body composition, sarcopenia, frailty, and their clinico-biological correlates, in Parkinson's disease2018/11/01English63
Diabetes mellitus is independently associated with more severe cognitive impairment in Parkinson disease2014/12/01English62
The adaptive deep brain stimulation challenge2016/07/01English62
A prospective study of falls in relation to freezing of gait and response fluctuations in Parkinson's disease2018/01/01English62
Orthostatic hypotension in Parkinson's disease: Does it matter if asymptomatic?2016/12/01English62
Visual complaints and visual hallucinations in Parkinson's disease2014/03/01English62
Impaired cognitive functions in adult-onset primary cranial cervical dystonia2014/02/01English62
Motor and non-motor symptoms of 1453 patients with Parkinson's disease: Prevalence and risks2013/08/01English62
Duodopa® treatment for advanced Parkinson's disease: A review of efficacy and safety2012/09/01English61
Plantar cutaneous sensory stimulation improves single-limb support time, and EMG activation patterns among individuals with Parkinson's disease2009/11/01English61
LRRK2 G2019S mutation in Parkinson’s disease: A neuropsychological and neuropsychiatric study in a large Algerian cohort2010/12/01English61
Essential tremor quantification during activities of daily living2011/08/01English61
Genetic variant of HTR2A associates with risk of impulse control and repetitive behaviors in Parkinson’s disease2012/01/01English61